Totally agree. I am not expecting much other than a restatement of how well the trial has gone. Anything else is icing. this is an opportunity to remind the medical community of PTX100 and Prescient.
The implications and follow through into Q1 2024 with potential FDA developments or partners is what will drive SP
Totally agree. I am not expecting much other than a restatement...
-
- There are more pages in this discussion • 232 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $33.01M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 4.1¢ | $2.136K | 52.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1355574 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 52961 | 1 |
View Market Depth
| Last trade - 13.50pm 05/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |